Trial · NCT03005288
Results by group45
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 45
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Total Body Fat Mass by Dual Energy X-ray Absorptiometry (DXA) at Week 48 | BYM338 10 mg/kg | -7.49 | 80% Confidence Interval -8.33 to -6.64 | kg | |
| Change From Baseline in Total Body Fat Mass by Dual Energy X-ray Absorptiometry (DXA) at Week 48 | Placebo | -0.18 | 80% Confidence Interval -0.99 to 0.63 | kg | |
| Change From Baseline in Total Body Fat Mass by Dual Energy X-ray Absorptiometry (DXA) at Week 24 | BYM338 10 mg/kg | -5.37 | 80% Confidence Interval -5.96 to -4.78 | kg | |
| Change From Baseline in Total Body Fat Mass by Dual Energy X-ray Absorptiometry (DXA) at Week 24 | Placebo | -0.18 | 80% Confidence Interval -0.75 to 0.39 | kg | |
| Change From Baseline in HbA1c at Week 24 and 48 | BYM338 10 mg/kg | week 24 | -0.85 | 80% Confidence Interval -1.06 to -0.64 | percentage change |
| Change From Baseline in HbA1c at Week 24 and 48 | Placebo | week 24 | 0.28 | 80% Confidence Interval 0.08 to 0.48 | percentage change |
| Change From Baseline in HbA1c at Week 24 and 48 | BYM338 10 mg/kg | week 48 | -0.76 | 80% Confidence Interval -1.05 to -0.48 | percentage change |
| Change From Baseline in HbA1c at Week 24 and 48 | Placebo | week 48 | 0.04 | 80% Confidence Interval -0.23 to 0.31 | percentage change |
| The Trough Observed Analyte Concentration (Ctrough) of Repeat Doses of BYM338 10 mg/kg on Day 84, 168, 252, 308 and 336 | BYM338 10 mg/kg | Day 84 | 25.3 | Standard Deviation 6.20 | μg/mL |
| The Trough Observed Analyte Concentration (Ctrough) of Repeat Doses of BYM338 10 mg/kg on Day 84, 168, 252, 308 and 336 | BYM338 10 mg/kg | Day 168 | 27.5 | Standard Deviation 8.37 | μg/mL |
| The Trough Observed Analyte Concentration (Ctrough) of Repeat Doses of BYM338 10 mg/kg on Day 84, 168, 252, 308 and 336 | BYM338 10 mg/kg | Day 252 | 31.0 | Standard Deviation 11.2 | μg/mL |
| The Trough Observed Analyte Concentration (Ctrough) of Repeat Doses of BYM338 10 mg/kg on Day 84, 168, 252, 308 and 336 | BYM338 10 mg/kg | Day 308 | 29.9 | Standard Deviation 11.0 | μg/mL |
| The Trough Observed Analyte Concentration (Ctrough) of Repeat Doses of BYM338 10 mg/kg on Day 84, 168, 252, 308 and 336 | BYM338 10 mg/kg | Day 336 | 27.8 | Standard Deviation 10.9 | μg/mL |
| Maximum Observed Serum Concentration(Cmax) Derived on Day 1, 168 and 308 | BYM338 10 mg/kg | Day 1 | 283 | Standard Deviation 32.0 | μg/mL |
| Maximum Observed Serum Concentration(Cmax) Derived on Day 1, 168 and 308 | BYM338 10 mg/kg | Day 168 | 292 | Standard Deviation 45.3 | μg/mL |
| Maximum Observed Serum Concentration(Cmax) Derived on Day 1, 168 and 308 | BYM338 10 mg/kg | Day 308 | 271 | Standard Deviation 31.1 | μg/mL |
| Time to Reach the Maximum Concentration After Drug Administration (Tmax) Derived on Day 168 and 308 | BYM338 10 mg/kg | Day 1 | 0.750 | Inter-Quartile Range 0.683 to 0.917 | hr |
| Time to Reach the Maximum Concentration After Drug Administration (Tmax) Derived on Day 168 and 308 | BYM338 10 mg/kg | Day 168 | 0.750 | Inter-Quartile Range 0.750 to 1.05 | hr |
| Time to Reach the Maximum Concentration After Drug Administration (Tmax) Derived on Day 168 and 308 | BYM338 10 mg/kg | Day 308 | 0.750 | Inter-Quartile Range 0.750 to 1.38 | hr |
| Change From Baseline in Body Mass Index (BMI) | BYM338 10 mg/kg | week 24 | -1.50 | 80% Confidence Interval -1.77 to -1.23 | Kg/m^2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03005288/results